Astera Labs (NASDAQ:ALAB) Trading Up 9.1% – Should You Buy?

Astera Labs, Inc. (NASDAQ:ALABGet Free Report) shot up 9.1% during mid-day trading on Thursday . The company traded as high as $293.92 and last traded at $293.56. 4,133,301 shares traded hands during trading, a decline of 21% from the average session volume of 5,247,150 shares. The stock had previously closed at $269.18.

Wall Street Analysts Forecast Growth

Several research firms have commented on ALAB. Roth Capital reaffirmed a “buy” rating and set a $450.00 price objective on shares of Astera Labs in a research note on Wednesday, August 5th. Stifel Nicolaus upped their price target on Astera Labs from $260.00 to $460.00 and gave the stock a “buy” rating in a research note on Wednesday, June 24th. Bank of America increased their price target on Astera Labs from $240.00 to $450.00 and gave the stock a “neutral” rating in a report on Tuesday, June 23rd. Jefferies Financial Group lifted their price objective on shares of Astera Labs from $270.00 to $450.00 and gave the company a “buy” rating in a research report on Wednesday, August 5th. Finally, UBS Group reissued a “neutral” rating and issued a $425.00 price objective on shares of Astera Labs in a research note on Wednesday, August 5th. One analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and eight have assigned a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $348.33.

Check Out Our Latest Stock Analysis on Astera Labs

Astera Labs Trading Up 3.3%

The stock has a market capitalization of $52.61 billion, a PE ratio of 150.12 and a beta of 3.77. The firm has a 50 day moving average of $303.33 and a two-hundred day moving average of $265.40.

Astera Labs (NASDAQ:ALABGet Free Report) last posted its earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The company had revenue of $392.40 million for the quarter, compared to the consensus estimate of $360.85 million. During the same period in the previous year, the business earned $0.44 earnings per share. Astera Labs’s quarterly revenue was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Equities research analysts forecast that Astera Labs, Inc. will post 2.7 EPS for the current year.

Insider Activity

In other Astera Labs news, Director Stefan Dyckerhoff sold 8,994 shares of Astera Labs stock in a transaction dated Thursday, August 6th. The shares were sold at an average price of $311.83, for a total transaction of $2,804,599.02. Following the completion of the transaction, the director owned 3,970 shares in the company, valued at approximately $1,237,965.10. The trade was a 69.38% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 90,630 shares of the stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the completion of the sale, the chief executive officer owned 1,266,665 shares in the company, valued at $431,109,432.75. This represents a 6.68% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 592,244 shares of company stock worth $209,729,973 in the last three months. Company insiders own 10.40% of the company’s stock.

Institutional Trading of Astera Labs

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Twin Peaks Capital Ltd acquired a new stake in shares of Astera Labs during the 2nd quarter worth about $4,830,000. Capstone Financial Advisors Inc. acquired a new position in shares of Astera Labs in the second quarter valued at approximately $274,000. Sequoia Financial Advisors LLC lifted its stake in shares of Astera Labs by 19.0% during the second quarter. Sequoia Financial Advisors LLC now owns 3,677 shares of the company’s stock valued at $1,776,000 after buying an additional 588 shares during the period. Archford Capital Strategies LLC acquired a new stake in Astera Labs during the second quarter worth approximately $506,000. Finally, Integrated Wealth Concepts LLC grew its stake in Astera Labs by 0.7% in the 2nd quarter. Integrated Wealth Concepts LLC now owns 7,006 shares of the company’s stock worth $3,384,000 after acquiring an additional 52 shares during the period. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

Astera Labs Company Profile

(Get Free Report)

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data-center operators, system manufacturers and other customers connect, expand and manage the high-speed components used in servers, storage systems and networking platforms.

The company’s portfolio includes PCI Express (PCIe) retimers and fabric switches, Compute Express Link (CXL) memory connectivity products, and Ethernet connectivity solutions.

Further Reading

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.